Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100355733C details a scalable 3-step route for 2-chloro-5-fluoro-nicotinic acid, eliminating toxic thiols and enabling cost-effective pharmaceutical intermediate manufacturing.
Patent CN115819186B reveals a safer Borane-THF reduction route for 3,5-dichlorobenzyl alcohol, eliminating genotoxic impurities and reducing manufacturing costs for pharmaceutical intermediates.
Novel oxidation-ammonolysis route for high-purity 6-amino-2-picolinic acid. Reduces equipment costs and improves yield for coordination chemistry applications.
Advanced synthesis of ursolic acid benzimidazole esters via patent CN102250188B. Offers cost reduction in pharmaceutical intermediate manufacturing and scalable routes.
Patent CN102863431A details a safe, scalable method for posaconazole production, eliminating hazardous hydrogenation steps for reliable pharmaceutical intermediates supply.
Novel boric acid-catalyzed route for 1,4-dialkoxy anthracene ensures high yield and safety. Ideal for anti-counterfeiting and optical applications.
Patent CN108610386A reveals a scalable synthesis for hexuronic acid glycosides. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with our advanced catalytic process.
Patent CN116396202A details a safe, scalable synthesis of (2S,4S)-4-fluoropyrrolidine-2-carboxylic acid using DeoxoFluor, offering significant cost reduction in API manufacturing.
Patent CN102850266A details a safer Roflumilast synthesis using KMnO4 and CDI, eliminating hazardous thionyl chloride for reliable pharmaceutical intermediates supply.
Patent CN109096148B reveals a novel one-pot method for Vorinostat using modified mesoporous silica, offering high purity and simplified supply chain for pharmaceutical manufacturers.
Patent CN116162074A reveals a novel alcohol-washing purification method for 2,5-furandicarboxylic acid, significantly reducing acid consumption and waste treatment costs for bio-based polymer manufacturers.
Discover a safe, cyanide-free synthesis for aminomethylbenzoic acid. High-yield pharmaceutical intermediate manufacturing with reduced environmental impact.
Patent CN103122012B reveals a streamlined synthesis for fondaparinux sodium intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced patent CN104860975B enables cost-effective bortezomib intermediate production. Enhanced yield and purity for reliable pharmaceutical supply chains.
Patent CN107200763B reveals a novel two-step synthesis for lithocholic acid. This method offers high purity and scalable production for pharmaceutical supply chains.
Patent CN110343056A reveals a cost-effective three-step synthesis route. This method ensures high purity and supply chain reliability for pharmaceutical intermediates.
Patent CN102558127B details a green microwave-assisted route for high-purity polyhydroxy flavones, offering significant cost reduction and scalability for pharmaceutical manufacturers.
Advanced preparation method for high-purity cefuroxime acid using ternary solvent extraction. Achieves >99% purity for antibiotic manufacturing with optimized supply chain efficiency.
Patent CN107324976B details a Cu-catalyzed decarboxylative coupling. Offers high yields and mild conditions for scalable API intermediate manufacturing.
Patent CN107879992B reveals a cost-effective 3-step route for this key antifungal intermediate, offering significant supply chain advantages for API manufacturers.